-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Neptune Wellness Solutions (NASDAQ:NEPT) Research Coverage Started at StockNews.com
Neptune Wellness Solutions (NASDAQ:NEPT) Research Coverage Started at StockNews.com
Equities researchers at StockNews.com started coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) in a research note issued on Friday. The firm set a "sell" rating on the biotechnology company's stock.
Neptune Wellness Solutions Price Performance
NEPT opened at $0.53 on Friday. The stock has a market capitalization of $6.21 million, a price-to-earnings ratio of -0.04 and a beta of 1.75. Neptune Wellness Solutions has a 12 month low of $0.23 and a 12 month high of $19.64. The company has a debt-to-equity ratio of 0.94, a current ratio of 0.87 and a quick ratio of 0.38. The business has a 50-day moving average of $0.62 and a two-hundred day moving average of $1.27.
Get Neptune Wellness Solutions alerts:Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) last released its quarterly earnings data on Friday, December 16th. The biotechnology company reported ($0.79) earnings per share for the quarter. The firm had revenue of $11.99 million during the quarter. Neptune Wellness Solutions had a negative net margin of 149.78% and a negative return on equity of 75.30%. On average, research analysts expect that Neptune Wellness Solutions will post -11.35 earnings per share for the current year.
Hedge Funds Weigh In On Neptune Wellness Solutions
Several hedge funds and other institutional investors have recently modified their holdings of the company. Virtu Financial LLC lifted its stake in shares of Neptune Wellness Solutions by 257.6% in the 1st quarter. Virtu Financial LLC now owns 554,376 shares of the biotechnology company's stock valued at $123,000 after purchasing an additional 399,362 shares in the last quarter. Renaissance Technologies LLC lifted its stake in shares of Neptune Wellness Solutions by 12.6% in the 3rd quarter. Renaissance Technologies LLC now owns 128,684 shares of the biotechnology company's stock valued at $196,000 after purchasing an additional 14,395 shares in the last quarter. Capital Wealth Alliance LLC acquired a new position in Neptune Wellness Solutions during the 2nd quarter worth approximately $57,000. Finally, Citadel Advisors LLC acquired a new position in Neptune Wellness Solutions during the 3rd quarter worth approximately $43,000. 5.07% of the stock is owned by institutional investors and hedge funds.Neptune Wellness Solutions Company Profile
(Get Rating)
Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.
Featured Articles
- Get a free copy of the StockNews.com research report on Neptune Wellness Solutions (NEPT)
- 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
- Optimism About Global Demand For Metals Boosts BHP, Other Miners
- Exxon Mobil Expects Earnings and Cash Flow to Grow
- Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
- Is The Great Alibaba Recovery About To Begin?
Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
Equities researchers at StockNews.com started coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) in a research note issued on Friday. The firm set a "sell" rating on the biotechnology company's stock.
StockNews.com的股票研究人员开始报道以下股票 海王星健康解决方案（纳斯达克股票代码：NEPT — 获取评级）（TSE: NTB） 在周五发布的研究报告中。该公司对这家生物技术公司的股票设定了 “卖出” 评级。
Neptune Wellness Solutions Price Performance
海王星健康解决方案价格表现
NEPT opened at $0.53 on Friday. The stock has a market capitalization of $6.21 million, a price-to-earnings ratio of -0.04 and a beta of 1.75. Neptune Wellness Solutions has a 12 month low of $0.23 and a 12 month high of $19.64. The company has a debt-to-equity ratio of 0.94, a current ratio of 0.87 and a quick ratio of 0.38. The business has a 50-day moving average of $0.62 and a two-hundred day moving average of $1.27.
NEPT周五开盘价为0.53美元。该股的市值为621万美元，市盈率为-0.04，beta值为1.75。Neptune Wellness Solutions创下12个月低点0.23美元，12个月高点为19.64美元。该公司的债务与权益比率为0.94，流动比率为0.87，速动比率为0.38。该公司的50天移动平均线为0.62美元，两百天移动平均线为1.27美元。
Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) last released its quarterly earnings data on Friday, December 16th. The biotechnology company reported ($0.79) earnings per share for the quarter. The firm had revenue of $11.99 million during the quarter. Neptune Wellness Solutions had a negative net margin of 149.78% and a negative return on equity of 75.30%. On average, research analysts expect that Neptune Wellness Solutions will post -11.35 earnings per share for the current year.
Neptune Wellness Solutions（纳斯达克股票代码：NEPT — 获取评级）（TSE: NTB）最后一次发布季度收益数据是在12月16日星期五。这家生物技术公司报告了本季度每股收益（0.79美元）。该公司在本季度的收入为1199万美元。Neptune Wellness Solutions的净利润率为负149.78％，负股本回报率为75.30％。研究分析师平均预计，Neptune Wellness Solutions本年度的每股收益将为-11.35美元。
Hedge Funds Weigh In On Neptune Wellness Solutions
对冲基金关注海王星健康解决方案
Neptune Wellness Solutions Company Profile
海王星健康解决方案公司简介
(Get Rating)
（获取评分）
Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.
Neptune Wellness Solutions Inc是一家健康和保健产品公司，专门从事大麻产品的提取、纯化和配方，以及其他特种成分，例如MaxSimil，一种增强脂质类营养品吸收的专利成分，以及其他各种海洋和种子油。
Featured Articles
精选文章
- Get a free copy of the StockNews.com research report on Neptune Wellness Solutions (NEPT)
- 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
- Optimism About Global Demand For Metals Boosts BHP, Other Miners
- Exxon Mobil Expects Earnings and Cash Flow to Grow
- Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
- Is The Great Alibaba Recovery About To Begin?
- 免费获取 StockNews.com 关于海王星健康解决方案 (NEPT) 的研究报告
- 3只可能在2023年实现大幅增长的小型生物制药股
- 对全球金属需求的乐观情绪提振了必和必拓和其他矿商
- 埃克森美孚预计收益和现金流将增长
- Sorrento Therapeutics，Scilex：两只热门制药股正在上涨
- 阿里巴巴的大复苏即将开始吗？
Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收海王星健康解决方案的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯，获取Neptune Wellness Solutions及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧